This website uses cookies
Read our Privacy policy and Terms of use for more information.
Jul 19, 2026
•
3 min read
Plus: the UK and Switzerland lock in pharma IP protections, Insilico's $2.5B pact with Bora, and AI discovery's shift to general design engines
Jul 12, 2026
5 min read
Plus: NICE turns down Lumykras, Boehringer's new eye-health research team, and whether longevity biotech's billions are backed by evidence
